News & Events

  • Additional recognition for B-SMART member

    The government of Galicia has awarded Prof. María José Alonso (Universidade de Santiago de Compostela (USC)) the Castelao Medal 2018. With this distinction the government of the Spanish region highlights her successful professional career and her valuable contribution to research on application of nanotechnology to pharmacy. María José Alonso will...
    Read more

  • Honours for female B-SMART scientists

    The Controlled Release Society (CRS) has announced the winners of their 2018 Awards. CRS was founded in 1978 as a non-profit organization devoted to the science and technology of controlled release. The field of controlled release encompasses scientific and technical efforts to regulate the spatial and temporal effects of agents in diverse areas...
    Read more

  • B-SMART workshop in Rome

    The B-SMART consortium, together with the EU-funded H2020 project STARBIOS2 and under the lead of B-SMART partner IBI, is organising the joint dissemination initiative “Alzheimer’s disease: from RNA research to active therapeutics”. The two European research projects B-SMART and STARBIOS2 come together to showcase their work, specifically...
    Read more

  • Important step in the research of RNAi therapeutics

    Alnylam Pharmaceuticals, the leading RNAi therapeutics company, announced that they have achieved delivery of novel small interfering RNA (siRNA) conjugates to the central nervous system (CNS) and are planning to advance a pipeline of investigational RNAi therapeutics into clinical development. The conjugates achieved robust, durable, and broadly...
    Read more

  • 2nd edition of B-SMART newsletter available!

    We are happy to announce the second edition of our B-SMART newsletter. It contains information on the first results of the project as well as news from the consortium and events announcements. Please have a look at B-SMART Newsletter // Issue No 2 // April 2018 and enjoy reading!
    Read more

  • First results!

    B-SMART has achieved first results in the development of RNA-based nanomedicines to treat neurodegenerative diseases. The scientists succeeded in developing an effective nanoparticle with customisable characteristics which is now being tested in a preclinical trial. In order to ensure scalability and a safe transfer of the scientific results to...
    Read more

  • Out now: The B-SMART animated clip is online

    We have released a short animated clip illustrating the project goals in an entertaining and understandable way, as well as highlighting the expected impact of the project results on European society. With this movie, we hope to raise awareness among a wide audience for the importance of nanomedicine in treating neurodegenerative diseases in...
    Read more

  • Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer’s disease

    B-SMART partner VIB announces the publication of a new paper in the journal EMBO Molecular Medicine. In it,  Prof. Roosmarijn Vandenbroucke and her research team report that tumor necrosis factor (TNF), via activation of its receptor TNFR1, is the main inflammatory upstream mediator of the with Alzheimer’s disease (AD) associated changes at...
    Read more